A Phase II Study of Paclitaxel and Topotecan With Filgrastim-SD/01 Support For Relapsed and Refractory Aggressive Non-Hodgkin's Lymphoma
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
The Methodist Hospital Research Institute
Alliance for Clinical Trials in Oncology
Fox Chase Cancer Center
H. Lee Moffitt Cancer Center and Research Institute
NYU Langone Health